Mariner’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Mariner's HALO Position: Q2 2026 in Review
Mariner reduced its Halozyme (HALO) stake by 28% in Q2 2026, selling an estimated $1.68M and leaving 62,044 shares worth $4.86M. The position accounts for 0.01% of the portfolio, ranked #1050.
Mariner first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. The position peaked at $6.37M in Q4 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Mariner held 62,044 shares of Halozyme worth $4.86M as of Q2 2026.
- Mariner sold 24,661 Halozyme shares in Q2 2026, an estimated $1.68M.
- Halozyme made up 0.01% of Mariner's portfolio in Q2 2026, its #1050 holding.
- Mariner first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
- Mariner's Halozyme position peaked at $6.37M in Q4 2025.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.